Agreed, if plasma derived AT III really works for DIC, then Atryn will work. The charitable thing is strange, they knew the company before and this certainly seems like a cover. Not a cover for a drug that doesn't work, just a cover for a company that didn't hold up their end of the bargain because of ennui or just bad judgement re pricing. Why is it so hard to shop this platform and this drug specifically? No interest from anyone we have ever heard of (I never heard of Ovation before but I sure am glad they are around!) Is it just the Galileo syndrome (but it moves!!) or are we missing something. I think its the fear factor of accepting new technology. bp